Brief: Basilea's Partner Asahi Kasei Pharma Files New Drug Application In Japan
Sept 30 (Reuters) - BASILEA PHARMACEUTICALS BSLN.S :
* BASILEA'S PARTNER ASAHI KASEI PHARMA FILED NEW DRUG
APPLICATION
FOR MARKETING AUTHORIZATION OF ISAVUCONAZOLE IN JAPAN
* BASILEA PHARMACEUTICA AG - FILING TRIGGERS A CHF 5 MILLION
MILESTONE PAYMENT FROM ASAHI KASEI PHARMA TO BASILEA
Source text for Eikon: ID:nGNE4rjQWt
Further company coverage: BSLN.S
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Basilea Pharmaceutica AG, Allschwil
See all newsBrief: Basilea Pharmaceutica - Strong Cresemba Sales In Europe Trigger USD 37.5 Mln Milestone Payment
Basilea seen up after raising 2026 guidance
Brief: Basilea Expects 2026 Operating Profit Of CHF 115 Mln
Brief: Basilea Reports Presentation Of New Data For Fosmanogepix, Isavuconazole And Ceftobiprole At IDWeek 2026
RCS - Accession Theraptcs. - Accession Therapeutics: Board appointments